European Commission - Internal Market, Industry, Entrepreneurship and SMEs

For a better experience, please enable Javascript.

Grants aimed at reinforcing the complementarity of Phase 2 of the SME Instrument - Programme H2020 - for the Promotion of Business Investment in RDI

Title of measure
Full title in national language:
Ayudas dirigidas a reforzar la complementariedad de la Fase 2 del Instrumento PYME del Programa Horizonte 2020 para el Fomento de la Inversión Empresarial en I+D+I
Duration:
2014 to 2020
Policy objectives Plus
4.1. Direct funding to business R&D and innovation
Presentation of the measure:

The main purpose of the grants is to promote business research, development and innovation investment. It is of great importance for the productive tissue of Madrid to keep its competitiveness; to promote the modernisation, the application of new technologies, as well as the transfer of knowledge and technology. All this facilitates the organisational and technological adaptation of the business tissue, mainly composed by SMEs, to the current needs of the market and the development of new products and processes that meet those needs and demands.
Apart from involving R&D of products and processes, the activities of the projects must be linked to the strategic areas identified in the RIS3 Madrid, namely: Nanotechnology, Advanced Materials, Industrial and Space Technologies; Health, Biotechnology, Water and Agro-Food; Energy, Environment and Transport (including Aeronautics), Information and Communications Technologies.

Budget, source and type of funding
Year201620172018
National public funds
Regional public funds 150000015000001500000
EU Structural Funds 150000015000001500000
Private funds
Other
Total300000030000003000000
Form of funding provided
Grants
Policy learning
To what extent the measure can be considered as a success and worthy of policy learning?:
It is too early to judge the success of the measure (e.g results of first call for proposals still not known).
Evidence of outcomes based on evaluation and other evidence:

There are no results to analyse yet.
 

What are the most important “Do’s and Don’ts” that regional stakeholders should be aware of when launching a similar measure?:

The measure supports RDI projects developed by regional SMEs in the fields identified as strategic in the RIS3 Madrid. SMEs constitute 99% of the regional productive tissue and therefore; it is essential to encourage them to invest in RDI. In this context, the grants act as an incentive to promote these type of activities while raising awareness of the multiple benefits linked to innovation.

Would you recommend this measure as an example of regional good practice to policy-makers from other regions ?:
Yes
Organisation(s) responsible